Epigenetics & Cancer Genomics

The field of cancer epigenetics is evolving rapidly on several fronts. Advances in our understanding of chromatin structure, histone modification, transcriptional activity and DNA methylation have resulted in an increasingly integrated view of epigenetics. In response to these insights, epigenetic therapy is expanding to include combinations of histone deacetylase inhibitors and DNA methyltransferase inhibitors. Zebularine, an orally administerable DNA methyltransferase inhibitor, has been a very promising recent addition to our arsenal of potentially useful drugs for epigenetic therapy. Epigenetics refers to alternate phenotypic states that are not based in differences in genotype, and are potentially reversible, but are generally stably maintained during cell division. The narrow interpretation of this concept is that of stable differential states of gene expression. 

The potential reversibility of epigenetic states offers exciting opportunities for novel cancer drugs that can reactivate epigenetically silenced tumor-suppressor genes. Epigenetic changes in cancer cells not only provide novel targets for drug therapy but also offer unique prospects for cancer diagnostics  The major interest in cancer epigenetics as a diagnostic tool is in localized epigenetic silencing. It is clear from this bird's-eye overview that the field of cancer epigeneticsis in flux. We can expect to see clinical implementation of both epigeneticcancer therapy and epigenetic cancer diagnostics in the next decade. Epigenetic control defects in cancer cells represent an emerging new area of investigation, where significant breakthroughs in the identification of the underlying molecular defects are anticipated in the next few years.

International Conference on Genetics Counseling and Genomics Medicine, Aug 11-12, 2016, Birmingham, UK; Biotechnology World Convention, Aug 15-17, 2016, Sao Paulo, Brazil; International Conference on Synthetic Biology, Aug 18-19, 2016, London, UK, Annual Conference on Bio Science, Sept 12-13, 2016, Berlin, Germany; Noncoding RNAs in Health and Disease, February 21-24, 2016, Santa Fe, USA; Maintenance of Genome Stability March 7- 10, 2016, Panama, South America; Chromatin and Epigenetics, March 20-24, 2016 Whistler, Canada; Chromatin, Non-Coding RNAs and RNAP II Regulation in Development and Disease, March 29, 2016, Austin, USA; Chromatin Structure & Function, May 22-27, 2016, Les Diablerets, Switzerland

  • Gene expression and epigenomics
  • Genes silencing
  • Cancer epigenetics
  • Cancer cells and genetic mutations
  • Cell based immunotherapy
  • Stem cell therapy for infectious diseases
  • Cell based immunosuppression in transplantation
  • Epigenetics of the antibody response
  • Epigenetic DNA repair and cancer

Related Conference of Epigenetics & Cancer Genomics

June 19-20, 2017

2nd International Conference on Bioscience

London, UK
July 03-05, 2017

7th World Summit on Plant Genomics

Bangkok, Thailand
July 20-22, 2017

15th Asia-Pacific Biotechnology Congress

Melbourne Australia
August 23-24 , 2017

6th International Conference on Tissue Engineering and Regenerative Medicine

San Francisco, California ,USA
August 23-24, 2017

3rd International Conference & Exhibition on Tissue Preservation and Biobanking

(10 Plenary Forums - 1 Event)
San Francisco, California, USA
September 14-15, 2017

2nd World Congress on HUMAN GENETICS

Edinburgh, Scotland
September 21-22, 2017

International Conference on Clinical and Medical Genetics

Toronto, Canada
September 25-27, 2017

17th Euro Biotechnology Congress

Berlin, Germany
September 27-28, 2017

Annual Summit on Cell Therapy and Molecular Medicine


(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 27-28, 2017

Annual Summit on Cell Signaling and Cancer Therapy


(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
October 16-17, 2017

3rd Annual Congress on Bioscience

Dubai,UAE
October 19-20, 2017

18th Biotechnology Congress

New York, USA
October 20-21, 2017

3rd World Congress on Human Genetics & Genetic Disorders

Toronto, Canada
October 23-24, 2017

10th World Congress on Stem Cell and Biobanking

Osaka, Japan
October 26-28, 2017

Stem Cells- 2017 (CME & CPD Accredited)

London, UK
November 13-14, 2017

19th World Congress on Biotechnology

Osaka, Japan
November 20-22, 2017

Genomics & Proteomics- 2017 (CME & CPD Accredited)

Rome, Italy
November 27-29, 2017

Transgenomics- 2017 (CME & CPD Accredited)

Frankfurt, Germany
December 04-05, 2017

2nd World Biotechnology Congress


(10 Plenary Forums - 1Event)
Sao Paulo, Brazil
December 11-12, 2017

3rd World Bio Summit & Expo

Dubai, UAE
August 07-08, 2018

11th world Congress on Cell & Tissue Science

Osaka, Japan
Heidelberg Germany

1st EMBL Conference Cancer Genomics Heidelberg Germany

1st to 4th November 2015
San Francisco CA United States of America

Genomic Sample Prep and Biomarker Assay Development DNA RNA Extraction NGS Assays Liquid Biopsy Antibody Validation More San Francisco United States of America

7th to 9th March 2016
San Francisco CA United States of America

Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America

7th to 9th March 2016
San Francisco CA United States of America

Genomics Sequencing Data Integration Analysis and Visualization San Francisco United States of America

10th to 11th March 2016
San Francisco CA United States of America

New Fronteirs in Gene Editing San Francisco United States of America

10th to 11th March 2016
London United Kingdom

HPLC Congress 2016 London United Kingdom

24th to 25th March 2016
Vienna Austria

2016 Genetics and Genomics Conference Vienna Austria

1st to 3rd June 2016
San Diego California United States of America

Genome Editing and Engineering Conference San Diego United States of America

18th to 19th February 2016
Breckenridge Colorado United States of America

Keystone Symposia Stem Cells and Cancer Breckenridge United States of America

6th to 10th March 2016
San Francisco CA United States of America

Clinical NGS Diagnostics Translating Genomic Data to the Standard of Care San Francisco United States of America

7th to 9th March 2016
Singapore

Human Genomics Singapore Singapore

8th to 10th November 2015
Kuala Lumpur Malaysia

The Probiotics Congress Asia Kuala Lumpur Malaysia

29th February to 1st March 2016

Epigenetics & Cancer Genomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in